Leonardi and his team at McMaster University in Hamilton, Canada are conducting an international survey study on the effect of Glucagon-Like Peptide (GLP)-1 medications on the management of endometriosis-related symptoms
While Hurtado advises against discontinuing medication, she noted that dietary, exercise, and behavior support should be offered to everyone throughout their weight loss journey
doi: 10.1016/S2213-8587(19)30180-9 10 MarsoSPDanielsGHBrown-FrandsenKKristensenPMannJFNauckMAet al
[PMID: 32547687] PubMed record related to this compound for laboratory literature review
If youre asking yourself, Is this real, and will it last? , the answer is yes, it can be a real experience for many, but its usually not permanent and absolutely manageable with the right support
However, Medicare Part D plans do cover Ozempic if prescribed for type 2 diabetes, not weight loss